Related Experiment Video

Updated: May 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

A "twist box" code of p53 inactivation: twist box: p53 interaction promotes p53 degradation

Sara Piccinin1, Elena Tonin, Sara Sessa

  • 1Experimental Oncology 1, CRO National Cancer Institute, Aviano 33081, Italy. spiccinin@cro.it

Cancer Cell
|September 15, 2012
PubMed

Insights

Twist1 protein inactivates p53 tumor suppressor in sarcomas via a novel mechanism. Targeting the Twist box interaction with p53 may offer new cancer treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Twist proteins are implicated in cancer development and progression.
  • The precise mechanisms by which Twist proteins exert their functions are not fully understood.
  • Understanding Twist protein roles is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the role of Twist1 in sarcoma development.
  • To elucidate the mechanism by which Twist1 influences p53 tumor suppressor activity.
  • To explore the potential of targeting the Twist1-p53 interaction for cancer treatment.

Main Methods:

  • Investigated Twist1 function in mesenchymal tumors.
  • Analyzed the interaction between Twist1 and p53.
  • Assessed the impact of Twist1 on p53 posttranslational modifications and degradation.
  • Evaluated the potential of targeting the Twist box:p53 interaction.

Main Results:

  • Twist1 inactivates p53 in mesenchymal tumors as an alternative to TP53 mutation or MDM2 overexpression.
  • Twist1 binds to the C-terminus of p53 via its Twist box domain.
  • This interaction inhibits critical p53 posttranslational modifications.
  • Twist1 binding facilitates MDM2-mediated degradation of p53.
  • Evidence suggests a 'Twist box code' for p53 inactivation.

Conclusions:

  • Twist1 plays a significant role in p53 inactivation in sarcomas.
  • The Twist box:p53 interaction represents a novel mechanism of tumor suppression.
  • Targeting this interaction could provide new therapeutic strategies for cancers involving Twist1.
  • Further research into the Twist box code could reveal broader implications for cancer therapy.

More Related Videos

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.